Skip to the page

Data / Drug companies / Testosterone

Testosterone: 22 companies and 47 products in the FDA NDC directory

Testosterone is listed in the FDA National Drug Code Directory by 22 companies, with 47 products in commercial distribution. 35 of the products (74.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are gel; gel, metered; solution, and the newest product started marketing on June 19, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
22
Products
47
Generic (ANDA) products
35 (74.5%)
Application numbers
24
Controlled substance schedule
Schedule III
Routes
Topical, Transdermal, Subcutaneous, Oral, Nasal
Brand names
Vogelxo, Testopel, Natesto Nasal Gel, Testim
openFDA record search
api.fda.gov

Companies that list testosterone

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Actavis Pharma, Inc.7gel; solutionGeneric drugs (ANDA)February 12, 2021
Prasco Laboratories5gelAuthorized generics (NDA)May 19, 2025
Padagis Israel Pharmaceuticals Ltd4gel; solutionGeneric drugs (ANDA)June 27, 2019
Bryant Ranch Prepack3solution; gel, meteredGeneric drugs (ANDA)May 8, 2020
Bryant Ranch Prepack3gel, metered; solutionGeneric drugs (ANDA)May 8, 2020
Alembic Pharmaceuticals Inc.2solution; gelGeneric drugs (ANDA)December 8, 2021
Encube Ethicals, Inc.2solution; gelGeneric drugs (ANDA)June 19, 2026
Endo USA, Inc.2pellet; gelGeneric drugs (ANDA)October 31, 2014
Lupin Pharmaceuticals, Inc.2solution; gelGeneric drugs (ANDA)April 10, 2019
NorthStar Rx LLC2gelGeneric drugs (ANDA)November 6, 2019
Strides Pharma Science Limited2gelGeneric drugs (ANDA)June 27, 2022
Upsher-Smith Laboratories, LLC2gel; gel, meteredAuthorized generics (NDA)June 16, 2014
Upsher-Smith Laboratories, LLC2gel; gel, meteredNew drug applications (NDA)June 9, 2014
Acerus Pharmaceuticals Corporation1gel, meteredNew drug applications (NDA)May 8, 2020
Amneal Pharmaceuticals NY LLC1gel, meteredGeneric drugs (ANDA)April 10, 2019
Bryant Ranch Prepack1gelGeneric drugs (ANDA)October 12, 2018
Cipla USA Inc.1solutionGeneric drugs (ANDA)March 30, 2018
Deseret Biologicals, Inc.1liquidUnapproved homeopathic productsJune 18, 2018
Dr. Reddy's Laboratories Inc.1gel, meteredGeneric drugs (ANDA)April 12, 2019
NorthStar RxLLC1gel, meteredGeneric drugs (ANDA)January 24, 2024
Upsher-Smith Laboratories, LLC1gelGeneric drugs (ANDA)December 31, 2019
Xiromed, LLC1gel, meteredGeneric drugs (ANDA)May 8, 2020

Dosage forms

Dosage formProductsShare
Gel2859.6%
Gel, metered919.1%
Solution817%
Pellet12.1%
Liquid12.1%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)3574.5%
Authorized generics (NDA)714.9%
New drug applications (NDA)48.5%
Unapproved homeopathic products12.1%

Pharmacologic classes

ClassProducts
Androgen47

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.